A cohort study on the association of MDM2 SNP309 with lung cancer risk in Bangladeshi population
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Bangladesh is a densely populated country with an increased incidence of lung cancer, mostly due to smoking. Therefore, elucidating the association of mouse double minute 2 homolog (MDM2) single nucleotide polymorphism (SNP) 309 (rs2279744) with lung cancer risk from smoking in Bangladeshi population has become necessary. Methods: DNA was extracted from blood samples of 126 lung cancer patient and 133 healthy controls. The MDM2 SNP309 was genotyped by polymerase chain reaction- restriction fragment length polymorphism (PCR-RFLP), using the restriction enzymes MspA1I. Logistic regression was then carried out to calculate odds ratios (ORs) and 95% confidence intervals (CIs) to estimate the risk of lung cancer. A meta-analysis of SNP309 was also carried out on 12,758 control subjects and 11,638 patient subjects. Results: In multivariate logistic regression, significantly increased risk of lung cancer was observed for MDM2 SNP309 in the dominant model (TG + GG vs. TT: OR, 2.13; 95% CI, 1.29 to 3.53). Stratification analysis revealed that age, sex, obesity, and smoking also increases the risk of lung cancer when carrying the MDM2 SNP309. Our meta-analysis revealed that MDM2 SNP309 was considerably associated with lung cancer in Asian populations (TG + GG vs. TT: OR, 1.32; 95% CI , 1.12 to 1.56; p = 0.019 for heterogeneity). Conclusions: The MDM2 SNP309 was associated with high risk of lung cancer in Bangladeshi and Asian population, particularly with increased age, smoking, and body mass index.
Abstract
Background/Aims: Bangladesh is a densely populated country with an increased incidence of lung cancer, mostly due to smoking. Therefore, elucidating the association of mouse double minute 2 homolog (MDM2) single nucleotide polymorphism (SNP) 309 (rs2279744) with lung cancer risk from smoking in Bangladeshi population has become necessary. Methods: DNA was extracted from blood samples of 126 lung cancer patient and 133 healthy controls. The MDM2 SNP309 was genotyped by polymerase chain reaction- restriction fragment length polymorphism (PCR-RFLP), using the restriction enzymes MspA1I. Logistic regression was then carried out to calculate odds ratios (ORs) and 95% confidence intervals (CIs) to estimate the risk of lung cancer. A meta-analysis of SNP309 was also carried out on 12,758 control subjects and 11,638 patient subjects. Results: In multivariate logistic regression, significantly increased risk of lung cancer was observed for MDM2 SNP309 in the dominant model (TG + GG vs. TT: OR, 2.13; 95% CI, 1.29 to 3.53). Stratification analysis revealed that age, sex, obesity, and smoking also increases the risk of lung cancer when carrying the MDM2 SNP309. Our meta-analysis revealed that MDM2 SNP309 was considerably associated with lung cancer in Asian populations (TG + GG vs. TT: OR, 1.32; 95% CI , 1.12 to 1.56; p = 0.019 for heterogeneity). Conclusions: The MDM2 SNP309 was associated with high risk of lung cancer in Bangladeshi and Asian population, particularly with increased age, smoking, and body mass index.
참고문헌 (40)
- Ozlu T, "Smoking and lung cancer", Tuberk Toraks, 53, pp.200~209 (2005)
- Bjartveit K, "Health consequences of smoking 1-4 cigarettes per day", Tob Control, 14, pp.315~320 (2005)
- Jemal A, "Cancer statistics, 2004", CA Cancer J Clin, 54, pp.8~29 (2004)
- Dela Cruz CS, "Lung cancer : epidemiology, etiology, and prevention", Clin Chest Med, 32, pp.605~644 (2011)
- Schottenfeld D, "The epidemiology of cancer : an overview", Cancer, 47(5 Suppl), pp.1095~1108 (1981)
- Ridge CA, "Epidemiology of lung cancer", Semin Intervent Radiol, 30, pp.93~98 (2013)
- Carreras-Torres R, "Obesity, metabolic factors and risk of different histological types of lung cancer : a Mendelian randomization study", PLoS One, 12, pp.e0177875~ (2017)
- Wade M, "Hdmx modulates the outcome of p53 activation in human tumor cells", J Biol Chem, 281, pp.33036~33044 (2006)
- Iwakuma T, "MDM2, an introduction", Mol Cancer Res, 1, pp.993~1000 (2003)
- Chowdhury MK, "TP53 codon 72 polymorphisms and lung cancer risk in the Bangladeshi population", Asian Pac J Cancer Prev, 16, pp.3493~3498 (2015)
- Zhuo W, "Association of MDM2 SNP309 variation with lung cancer risk : evidence from 7196 cases and 8456 controls", PLoS One, 7, pp.e41546~ (2012)
- Hu Z, "Genetic variants in the MDM2promoter and lung cancer risk in a Chinese population", Int J Cancer, 118, pp.1275~1278 (2006)
- Li G, "MDM2 gene promoter polymorphisms and risk of lung cancer : a case-control analysis", Carcinogenesis, 27, pp.2028~2033 (2006)
- Lind H, "Association of a functional polymorphism in the promoter of the MDM2 gene with risk of nonsmall cell lung cancer", Int J Cancer, 119, pp.718~721 (2006)
- Park SH, "MDM2 309T>G polymorphism and risk of lung cancer in a Korean population", Lung Cancer, 54, pp.19~24 (2006)
- Pine SR, "MDM2 SNP309and SNP354 are not associated with lung cancer risk", Cancer Epidemiol Biomarkers Prev, 15, pp.1559~1561 (2006)
- Zhang X, "Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer", Hum Mutat, 27, pp.110~117 (2006)
- Liu G, "Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk", Int J Cancer, 122, pp.915~918 (2008)
- Mittelstrass K, "Early onset lung cancer, cigarette smoking and the SNP309 of the murine double minute-2(MDM2)gene", BMC Cancer, 8, pp.113~ (2008)
- Chua HW, "Effect of MDM2 SNP309and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in Singapore", BMC Cancer, 10, pp.88~ (2010)
- Kohno T, "Contribution of the TP53, OGG1, CHRNA3, and HLA-DQA1 genes to the risk for lung squamous cell carcinoma", J Thorac Oncol, 6, pp.813~817 (2011)
- Ryan BM, "MDM2 SNP285does not antagonize the effect of SNP309 in lung cancer", Int J Cancer, 131, pp.2710~2716 (2012)
- Ren YW, "P53 Arg72Pro and MDM2SNP309 polymorphisms cooperate to increase lung adenocarcinoma risk in Chinese female non-smokers : a case control study", Asian Pac J Cancer Prev, 14, pp.5415~5420 (2013)
- Gansmo LB, "Influence of MDM2 SNP309 and SNP285 status on the risk of cancer in the breast, prostate, lung and colon", Int J Cancer, 137, pp.96~103 (2015)
- Li W, "Association of p73 gene G4C14-A4T14 polymorphism and MDM2 gene SNP309with non-small cell lung cancer risk in a Chinese population", Oncol Lett, 14, pp.1817~1822 (2017)
- Mantel N, "Statistical aspects of the analysis of data from retrospective studies of disease", J Natl Cancer Inst, 22, pp.719~748 (1959)
- Egger M, "Bias in meta-analysis detected by a simple, graphical test", BMJ, 315, pp.629~634 (1997)
- Begg CB, "Operating characteristics of a rank correlation test for publication bias", Biometrics, 50, pp.1088~1101 (1994)
- Gauderman WJ, "Testing association between disease and multiple SNPs in a candidate gene", Genet Epidemiol, 31, pp.383~395 (2007)
- Grossman SR, "p300", MDM2 complexes participate in MDM2-mediated p53 degradation, 1998, pp.2, 405~415
- Dai MS, "Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2", Mol Cell Biol, 28, pp.4365~4376 (2008)
- Hu W, "A single nucleotide polymorphism in the MDM2 gene disrupts the oscillation of p53and MDM2 levels in cells", Cancer Res, 67, pp.2757~2765 (2007)
- Xiao ZX, "Interaction between the retinoblastoma protein and the oncoprotein MDM2", Nature, 375, pp.694~698 (1995)
- Ries S, "Opposing effects of Ras on p53 : transcriptional activation of mdm2 and induction of p19ARF", Cell, 103, pp.321~330 (2000)
- Han JY, "Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer", Cancer, 113, pp.799~807 (2008)
- Sun S, "Lung cancer in never smokers : a different disease", Nat Rev Cancer, 7, pp.778~790 (2007)
- Subramanian J, "Lung cancer in never smokers : a review", J Clin Oncol, 25, pp.561~570 (2007)
- Mulvihill JJ, "Preconception exposure to mutagens : medical and other exposures to radiation and chemicals", J Community Genet, 3, pp.205~211 (2012)
- Bai J, "Cigarette smoking, MDM2 SNP309, gene-environment interactions, and lung cancer risk : a meta-analysis", J Toxicol Environ Health A, 72, pp.677~682 (2009)
- He W, "MDM2 SNP309 polymorphism is associated with lung cancer risk in women : a meta-analysis using METAGEN", Exp Ther Med, 4, pp.569~576 (2012)